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Abstract 27 
Purpose: We investigated the effects of an acute 24-h nitrate-rich beetroot juice supplement 28 
(BR) on the energy cost, exercise efficiency and blood pressure responses to intermittent 29 
walking at different gradients. Methods: In a double-blind, cross-over design, eight 30 
participants were provided with a total of 350 ml of nitrate-rich (~20.5 mmol nitrate) BR or 31 
placebo (PLA) across 24-h before completing intermittent walking at 3 km/h on treadmill at 32 
gradients of 1%, 5%, 10%, 15% and 20%. Results: Resting mean arterial pressure (MAP) 33 
was ~4.1% lower after BR (93 vs. 89 mmHg; P = 0.001), as well as during exercise (102 vs. 34 
99 mmHg; P = 0.011) and recovery (97 vs. 94 mmHg; P = 0.001). Exercising (1227 vs. 1129 35 
ml/min P < 0.001) and end-stage (1404 vs. 1249 ml/min; P = 0.002) oxygen uptake (?̇?O2) was 36 
lower in BR compared to PLA, which was accompanied by an average reduction in phase II 37 
?̇?O2 amplitude (1067 vs. 940 ml/min; P = 0.025). Similarly, recovery ?̇?O2 (509 vs. 458 38 
ml/min; P = 0.001) was lower in BR. Whole-blood potassium concentration increased from 39 
pre-post exercise in PLA (4.1 ± 0.3 vs. 4.5 ± 0.3 mmol/L; P = 0.013) but not BR (4.1 ± 0.31 40 
vs. 4.3 ± 0.2 mmol/L; P = 0.188). Conclusions: Energy cost of exercise, recovery of ?̇?O2, 41 
MAP and blood markers were ameliorated after BR. Previously reported mechanisms explain 42 
these findings, which are more noticeable during less efficient walking at steep gradients (15-43 
20%). These findings have practical implications for hill-walkers. 44 
 45 
Key words: Nitrate; efficiency; energy cost; blood pressure. 46 
 47 
 48 
 49 
 50 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
 
Abbreviations 51 
Adenosine triphosphate (ATP)  52 
Beetroot juice (BR) 53 
Blood lactate concentration (B[La]) 54 
Blood potassium concentration ([K+]) 55 
Blood pressure (BP) 56 
Coefficient of variation (CV%) 57 
Diastolic (DP) 58 
Energy cost of walking (Cw) 59 
Glucose concentration ([Glu]) 60 
Gross efficiency (GE%) 61 
Heart rate (HR)  62 
Mean arterial pressure (MAP) 63 
Nitrate (NO3̅) 64 
Nitrite (NO2̅)  65 
Nitric oxide (NO) 66 
Oxygen uptake (?̇?O2) 67 
Placebo (PLA) 68 
Rating of perceived exertion (RPE) 69 
Sarcoplasmic reticulum calcium (SR-Ca2+) 70 
Systolic pressure (SP)  71 
Ventilatory threshold (VT) 72 
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Introduction 78 
Supplementation of inorganic nitrate (NO3̅), in the form of a highly-concentrated beetroot 79 
juice (BR) supplement (5.2 - 8.2 mmol of NO3
- per day), improves endurance performance 80 
(Bailey et al. 2009, 2010, 2015; Bryan et al. 2008; Lansley et al. 2011a; Wylie et al. 2013). 81 
These effects are thought to be facilitated by the oxygen independent reductions of NO3
-
 to 82 
nitrite (NO2
-) and nitric oxide (NO) (Bailey et al. 2012). The NO3
--NO2
--NO cascade 83 
increases circulating NO2
-
, which can be further reduced to NO under certain physiological 84 
conditions (Bryan et al. 2008). Thus, the availability of NO can be preserved when enzymatic 85 
synthesis of NO via nitric oxide synthase (NOS) has been compromised (Bryan et al. 2008). 86 
The role of the NO3
--NO2
--NO pathway is potentiated during intense exercise, in particular, 87 
owing to the mild hypoxic and/or acidic conditions induced in the working skeletal muscle 88 
(Jones et al. 2016).   89 
 90 
Nitric oxide is a key regulator of blood pressure (BP) and a signalling molecule for smooth 91 
muscle surrounding the endothelium (Gilchrist et al. 2011). These mechanisms permit 92 
vasodilation of blood vessels and enhance blood flow to the working musculature (Ferguson 93 
et al. 2013). Accordingly, reduced BP is common after NO3
- supplementation during rest 94 
(Bailey et al. 2009; Bond et al. 2013, 2014; Kapil et al. 2010; Vanhatalo et al. 2010; Webb et 95 
al. 2008) and exercise (Bond et al. 2013, 2014; Choi et al. 2016; Kenjale et al. 2011; Oggioni 96 
et al. 2017). The combination of increased muscle blood flow and reduced oxygen extraction 97 
at the site of the working musculature leads to enhanced exercise tolerance (Bailey et al. 98 
2010). The latter finding has been attributed to an enhanced efficiency of oxidative adenosine 99 
triphosphate (ATP) turnover in the mitochondria (Larsen et al. 2011). Mammalian studies 100 
have demonstrated that other factors, such as improved sarcoplasmic reticulum calcium (SR-101 
Ca2+) handling, might also contribute to improved exercise tolerance following NO3
- 102 
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supplementation (Hernández et al. 2011). However, recent studies have demonstrated that 103 
longer (> 7 days) supplementation periods would be necessary to induce such changes in 104 
calcium handling proteins and point to alternative mechanisms, such as increased emission of 105 
mitochondrial reactive oxygen species and their possible effects on muscle contractile 106 
apparatus (Whifield et al. 2016). Nevertheless, these mechanisms contribute to a decreased 107 
ATP turnover for a given power output (Bailey et al. 2010), thus improving exercise 108 
economy across a variety of work-rates, with a notable 12 % reduction in the O2 cost (?̇?O2 109 
amplitude) of walking at fixed gradients of 1% (Lansley et al. 2011b) and preferable 110 
alterations in the pulmonary oxygen uptake (?̇?O2) kinetics of older adults (Kelly et al. 2013).  111 
 112 
BR supplementation has not improved endurance performance or lowered exercising ?̇?O2 in 113 
all cases, particularly when administered to elite endurance athletes (Christensen et al. 2012; 114 
Peacock et al. 2012; Boorsma et al. 2014). The inconsistent findings have been ascribed to 115 
the aerobic fitness level of the athletes (Porcelli et al. 2015) and might relate to the lower 116 
reliance on the NO3
--NO2
--NO pathway or the presumed higher proportions of type I muscle 117 
fibre among well-trained endurance athletes. This is consistent with the evidence that the 118 
effects of NO3
- are potentiated in type II muscle fibre (Hernández et al. 2011; Ferguson et al. 119 
2013). As such, certain forms of locomotion that mandate the recruitment of type II muscle 120 
fibre could be affected differently by BR supplementation compared to those without, 121 
particularly when performed by non-elite athletes.  122 
    123 
Incline walking is a popular and effective mode of exercise for physical fitness (Ainslie et al. 124 
2002, 2005; Gottschall and Kram 2006) but will present a challenge to certain populations or 125 
vocations. The energy cost of walking (Cw) increases as a function of surface incline (Minetti 126 
et al. 2006). The external work done to walk on gradients between 1% and 20% comprises a 127 
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combination of negative and positive contributions (Minetti et al. 2006). On extreme uphill 128 
slopes (20%), this work becomes entirely positive and reaches a mechanical efficiency (i.e. 129 
ratio of mechanical work for vertical displacement to the energy expended) equivalent to 130 
concentric muscle contraction (Margaria et al. 1963). Negative work is more efficient (~ 131 
80%), yet diminishes as a function of walking gradient, meaning there is a greater reliance on 132 
less efficient (~ 25%) positive work (Minetti et al. 2006). When walking uphill at 133 
progressively steeper inclines, muscle recruitment strategies are proportionally altered to 134 
coincide with the leading leg performing longer and more forceful concentric muscle 135 
contractions (i.e. more positive work) (Gottschall and Kram 2006). Consequently, greater 136 
lower-limb muscle activation (Vernillo et al. 2017), anaerobic metabolism (Sloniger et al. 137 
1997; Staab et al. 1992) and perception of effort (Kolkhorst et al. 1996) is evident during 138 
uphill locomotion, compared to level exercise at the same speed. These observations reflect a 139 
change in the muscle recruitment patterns of the lower limbs and a logical reliance on type II 140 
muscle fibres to support the more forceful and concentrically-biased muscle contraction. 141 
 142 
Whilst it is known that dietary NO3
- can enhance muscle efficiency in humans, rodent studies 143 
have shown that NO3
- supplementation can improve muscle O2 delivery in musculature with a 144 
high type II fibre distribution (Ferguson et al. 2013), where it also improves SR-Ca2+ storage 145 
and release (Hernández et al. 2011). It has recently been proposed that the ergogenic 146 
properties of NO3
- are fibre type dependent (Jones et al. 2016). In support of this, Breese et al. 147 
(2013) reported faster ?̇?O2 kinetics and improved time to exhaustion during step-exercise, 148 
designed to elicit the recruitment of higher order motor units. It is therefore feasible that 149 
consumption of NO3
- can improve the efficiency of uphill walking, owing to the constrained 150 
changes in gait pattern toward a less efficient form of locomotion and an increased reliance 151 
on type II muscle fibres as the gradient increases. Indeed, a recent study demonstrated 152 
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lowered ?̇?O2 after BR supplementation during loaded uphill walking at 10% gradients in 153 
hypoxic (fraction of inspired O2 = 11.7%) conditions (Shannon et al. 2017). However, the 154 
effects of BR supplementation on the physiological responses to incline walking at different 155 
gradients have not been systematically investigated among unloaded subjects in normoxic 156 
conditions. Accordingly, this study aimed to assess the effects of an acute 24-h NO3̅-rich BR 157 
supplement on the energy cost, exercise efficiency and BP responses to intermittent walking 158 
at different gradients. We hypothesized that the BR supplement would reduce the cost of 159 
exercise as a function of the exercise intensity and ameliorate recovery between exercise 160 
bouts, including a reduction in BP during rest and exercise.        161 
 162 
Methods 163 
 164 
Participants and design 165 
Eight participants (5 male (age 27 ± 2 years; stature 1.74 ± 0.09 m; body mass 81.4 ± 7.3 kg; 166 
?̇?O2max 56.8 ± 7.8 ml/kg/min) and 3 female (age 29 ± 5 years; stature 166 ± 4 cm; body mass 167 
60.0 ± 6.1 kg; ?̇?O2max 38.0 ± 10.4 ml/kg/min) provided written informed consent to take part 168 
in this study. The participants were all recreationally active and regularly hill-walked as part 169 
of their occupation or leisure activities. The participants were all naive to the effects of 170 
beetroot juice on exercise. After baseline measures and familiarisation, in a double-blind, 171 
randomized cross-over design, the participants were either supplemented with a total of 350 172 
ml of BR, in the form of beetroot shots, which were consumed at three evenly-spaced periods 173 
in the 24-h before the exercise trial, or a placebo (PLA), one week apart. After 24-h of 174 
supplementation, the participants completed a randomized, intermittent, inclined walking 175 
protocol on a treadmill, while their physiological (?̇?O2, blood lactate concentration (B[La]), 176 
blood potassium concentration ([K+]), heart rate (HR) and continuous BP), perceptual (rating 177 
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of perceived exertion; RPE) and gross mechanical work was measured. The participants were 178 
instructed to arrive at least 3-h post prandial, abstain from heavy exercise, caffeine intake, 179 
anti-bacterial mouthwash and NO3̅-rich foods in the 48-h before and during the study. Food 180 
diaries were completed to ensure compliance with these instructions. This study was granted 181 
institutional ethical approval and was conducted in accordance with the ethical standards laid 182 
down in the 1964 Declaration of Helsinki. 183 
 184 
Procedure 185 
Baseline measurements 186 
The participants visited the laboratory on three occasions. On their first visit, the participants 187 
were screened to ensure low-risk stratification, including assessment of resting BP and the 188 
completion of extended health questionnaires (Exercise Sport Science Australia). Resting BP 189 
was measured from the left brachial artery, using an automated sphygmomanometer (Omron 190 
M7 BP Monitor, OMRON Healthcare Europe, Hoofddrop, Netherlands) after sitting for 15- 191 
min in a quiet room. The average systolic (SP), diastolic (DP) and mean arterial pressures 192 
(MAP) of three measurements was recorded, calculated as: (MAP) (MAP = DBP + 0.33 193 
(SBP–DBP)). This method of BP measurement was adopted at baseline, for screening 194 
purposes, whereas continuous measurements were performed for all subsequent visits. A HR 195 
monitor was strapped across the participants’ chest and synchronized with a wrist watch 196 
(V800, Polar, Kempele, Finland) to record resting HR. Whilst seated in the same position, 197 
baseline venous blood was drawn from the participants’ right arm at the antecubital fossa, 198 
using a hypodermic needle and a lithium-heparinized vacutainer (4 ml). The whole blood was 199 
immediately tested for blood glucose ([Glu]) and [K+] concentrations using a mobile analyser 200 
(iSTAT analyser, Abbott Point of Care Inc, Princeton, NJ) with a manufacturer-reported 201 
coefficient of variation (CV%) of 1.1%. The remaining and whole blood was then centrifuged 202 
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at 4,000 r/min and 4 °C for 10-min, after which the plasma was immediately stored at -80 °C. 203 
Blood plasma was later thawed and analysed for NO3̅ using a colorimetric assay, with an 204 
intra-assay CV% of 2.7, and an ELISA with an intra-assay CV% of 6.3, respectively (see 205 
http://www.abnova.com/products/products_detail.asp?catalog_id=KA1342). Plasma insulin 206 
was measured using a solid phase two-site enzyme immunoassay, with an intra-assay CV% 207 
of 6.4 and an inter-assay CV of 8.5 (see 208 
http://www.abnova.com/products/products_detail.asp?catalog_id=KA0921) .  209 
 210 
The participants also completed an incremental, maximal treadmill test on their first visit, to 211 
establish ?̇?O2max and ventilatory threshold (VT). An adapted Bruce protocol was performed on 212 
a calibrated motorized treadmill (Mercury® Med, hpcosmos sports & medical gmbh; 213 
Nussdorf-Traunstein, Germany), beginning at 2.7 km/h and 0% gradient and increasing by 214 
speed and gradient every 3-min until volitional exhaustion. This test was selected to 215 
familiarize the participants to gradient walking, as well as incorporating a warm-up stage into 216 
the test and providing a measurement of ?̇?O2max. Pulmonary gas was measured continuously 217 
using a breath-by-breath gas analyser (Jaegar, Oxycon Pro, Viasys Healthcare, Hoechberg, 218 
Germany). The gas analyser and flow turbine were calibrated before each test using a known 219 
gas mixture (15% O2 and 5% CO2) and a 3-L syringe, respectively (Hans Rudolph, Kansas 220 
City, KS). ?̇?O2max was determined as the mean value recorded over the final 30-s of the test. 221 
The same gas analyser was used throughout the study and calibrated identically, with a CV% 222 
of 4.3. The VT was determined using the V-slope method, which has previously been used 223 
during 3-min incremental stages (Amman et al. 2004). The vertical mechanical power output 224 
(W) was calculated at the VT according to Minetti et al. (2006) as:  225 
 226 
Ẇvert = gv sin (arc tan [i])    [Eq. 1]  227 
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 228 
where g = gravity (m/s/s), v = treadmill velocity (m/s) and i = the treadmill gradient.    229 
 230 
The power output was subsequently used to delineate moderate and heavy exercise domains. 231 
The aim of the final experimental protocol was to exercise participants below the heavy 232 
exercise domain, at fixed gradients and speeds. As such, the power output at VT was 233 
measured to ensure that it was higher than the highest power output used in the final test 234 
protocol. The mean of the highest power output to be performed during the experimental trial 235 
was calculated a-priori as 108 ± 18 W, while the mean power output at VT was 165 ± 29 W, 236 
with no participants achieving a VT power output lower than the highest power output in the 237 
experimental protocol. Therefore, all participants were exercising below the heavy intensity 238 
domain during the study. The mean %?̇?O2max during the highest intensity (20 % gradient) 239 
trials was 52 ± 14 % and 48 ± 13 % in the PLA and BR conditions, respectively.  240 
 241 
Experimental protocol  242 
At baseline testing, the participants were randomly assigned to one of the two conditions and 243 
returned to the laboratory 24-h later (am) to receive their first of three supplements, in the 244 
form of two NO3̅-rich BR shots (2 x 70 ml ~ 4.1 mmol NO3̅ per shot; Beet it, James White 245 
Drinks Ltd., Ipswich, UK) or PLA (isocaloric fruit juice and maltodextrin mixture). The 246 
drinks were opened 10-min before their arrival at the laboratory and provided in identical 247 
opaque containers. The drinks were consumed within 30-s by all participants. The 248 
participants visited the laboratory to take their supplements on two further occasions across 249 
the subsequent 24-h period, with the second beverage (2 x 70 ml ~ 4.1 mmol NO3
- per shot or 250 
PLA) consumed mid-way between the first and final serving. The final drink (1 x 70 ml ~ 4.1 251 
mmol NO3̅ per shot or PLA) was consumed 1.5-h prior to testing (~2-2.5-h prior to exercise).  252 
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 253 
On the morning of each visit to the laboratory, resting BP, HR was measured and venous 254 
blood was drawn after 15-min of seated rest. The participants then mounted the treadmill and 255 
were fitted with a continuous BP monitor (Finometer MIDI, Finapres Medical Systems, 256 
Amsterdam, The Netherlands), designed to measure brachial BP using photoelectric 257 
plethysmography of the finger pressure waveform (Wesseling 1995). The Finapres® device 258 
was fitted to the left arm of each participant. Specifically, the device was fitted by securing an 259 
inflatable plastic bladder (50 µm and 55 mm length) between the distal and proximal inter-260 
phalangeal joint of the middle finger, which housed an infrared light-emitting diode (950 nm 261 
emission) and detector. This was connected to a front-end unit via an air hose. The front-end 262 
unit was attached to the left wrist using a Velcro strap. The front end was connected to the 263 
main unit and pump inside the Finometer MIDI. A height correction unit was also fitted to 264 
the front-end unit to automatically correct for hydrostatic pressure changes due to movement 265 
in hand position relative to the heart. During the experimental protocol, the participants 266 
walked with a natural arm carriage, with their fingers relaxed and without holding on to the 267 
treadmill. A laptop was connected to the Finometer MIDI and the raw 200 Hz data were 268 
analysed using the BeatScope® software (Version 1.1, Finapres Medical Systems BV, 269 
Arnhem, Netherlands). BeatScope® software was used to reconstruct mean brachial pressure 270 
from the finger-pulse pressure waveform. The Finapres® was activated 1-min prior to 271 
recording to allow for calibration. The calibration is performed automatically through the 272 
Physiocal software in the device, which was activated during the trials. Any interruption of 273 
the recording owing to calibration was removed from the data set. No further filtering was 274 
applied to the data. MAP was reported during exercising and resting conditions. The inter-275 
day walking MAP CV of this device ranged from 1.6-3.2 %, increasing as a function of 276 
exercise intensity (i.e. gradient).   277 
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 278 
Prior to exercise, a finger-prick capillary sample of blood was then drawn from the index 279 
finger of the participant whilst standing on the treadmill, which was measured for B[La] 280 
using a hand-held analyser (Lactate Pro; Arkray KDK Corp., Kyoto, Japan), which has a 281 
CV% of 3.1. The participants were then fitted with the face mask of the breath-by-breath gas 282 
analyser, where 3-min measurements of ?̇?O2, respiratory exchange ratio (RER), HR, and 283 
continuous BP were recorded during quiet standing. These measurements were continued for 284 
the remainder of the protocol. After quiet standing measurements, the participants began the 285 
intermittent walking trial, which comprised 5 × 5-min bouts of walking at randomized 1%, 286 
5%, 10%, 15% or 20% inclines, at a fixed speed of 3 km/h, with each exercise stage 287 
interspersed by 5-min of quiet standing. No talking was permitted by participants during the 288 
trial. B[La] was measured 1-min post exercise bout, while RPE was provided by the 289 
participants in the final 15-s of each bout. Final venous blood draws were performed no more 290 
than 5-min after the final exercise stage. 291 
 292 
The rest-recovery configuration of the protocol permitted the measurement of on-pulmonary 293 
?̇?O2 kinetics during intermittent exercise and prevented interference of ?̇?O2 responses 294 
between repeated exercising bouts. Raw ?̇?O2 data were filtered to remove errant breaths more 295 
than 4 SD from the local mean. After interpolating breath-by-breath data to 1-s values, the 296 
?̇?O2 on-kinetics were modelled using a non-linear least squares fitting procedure in a custom 297 
programme (Microsoft Excel). After excluding the first 20-s of data on-transients, a mono-298 
exponential model was used to characterize all trials, as they were performed below the 299 
heavy intensity domain. On-transients were modelled based eq. 2: 300 
 301 
∆?̇?O2(t) = base?̇?O2 + A [1 – e-(t - TD)/τ)]     [Eq. 2] 302 
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 303 
Where ∆?̇?O2(t) = absolute ?̇?O2 at a given time t; base?̇?O2 = baseline resting ?̇?O2; τ = 304 
fundamental time constant; TD = time delay and A = ?̇?O2 amplitude (i.e. ΔVO2 > base?̇?O2).  305 
 306 
The overall mean response time (MRT) was resolved by fitting a mono-exponential model to 307 
the ?̇?O2 data from 0-s to end exercise, without adding the time delay. The external 308 
mechanical work (W) was calculated based on published equations (Minetti et al. 2006; see 309 
Eq.1) and was used to determine gross efficiency (GE%) as the ratio of mechanical work 310 
done and metabolic energy, as measured via gas analysis. The energy cost of walking (Cw) 311 
was expressed as in joules (J) / kg body mass / min (J/kg/min), using the thermal equivalent 312 
of oxygen (20.9 J/L O2) (Minetti et al. 2006).     313 
 314 
Statistical analyses 315 
All data are presented as means ± SD, unless otherwise stated. A two-way repeated measures 316 
analysis of variance was used to evaluate the effects of condition (BR or PLA), gradient (1%, 317 
5%, 10%, 15% and 20%) and their interaction. If tests of Sphericity were violated, the 318 
Greenhouse-Giesser correction was used. In the event a statistical difference was identified, a 319 
post-hoc Bonferroni test was used to identify differences. An alpha level of P < 0.05 was set 320 
for all analyses. Effect sizes (d), calculated as the mean difference divided by the pooled 321 
standard deviation of scores, were included for pairwise comparisons to provide information 322 
on the magnitude of any effect. Effect sizes were defined as: trivial = 0.2; small = 0.21–0.6; 323 
moderate = 0.61–1.2; large = 1.21–1.99; very large > 2.0 (Hopkins et al. 2009). Statistical 324 
analysis was conducted through IBM SPSS (Software V22.0, IBM, New York, USA). 325 
 326 
 327 
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Results 328 
Plasma [NO3]̅ 329 
BR significantly elevated plasma [NO3̅] (340 ± 58 𝜇M) prior to exercise compared to 330 
baseline (90 ± 11 𝜇M, P < 0.001; d = 5.3) and PLA (89 ± 12 𝜇M, P = 0.001; d = 5.3). After 331 
the exercise protocol, plasma [NO3̅] was significantly reduced in BR (309 ± 45 𝜇M) but 332 
remained higher than PLA (86 ± 11 𝜇M, P < 0.001; d = 6.0). 333 
 334 
****Insert Table 1 here**** 335 
MAP during rest and exercise 336 
Resting MAP was ~4.1% lower after BR consumption compared to PLA (P = 0.001, d = 1.5). 337 
There were also main effects (independent of the exercise stage) for recovery (P = 0.001) and 338 
exercise MAP (P = 0.011), which in both cases was lower (average ~3.9% and ~2.4%, 339 
respectively) in BR than PLA (Figure 1). The interaction between exercise stage and 340 
supplement for exercise MAP approached significance (P = 0.056), with the highest mean 341 
difference in MAP present at a gradient of 1% (~4.1%; d = 0.98) and lowest at 20% (~1.7%; 342 
d = 0.3). 343 
 344 
****Insert Figure 1 here***** 345 
 346 
 347 
 348 
Cardiorespiratory measurements 349 
There were no differences between BR and PLA for resting (P = 0.699), exercise (P = 0.257) 350 
or recovery HR (P = 0.512) (Table 1). Pulmonary V̇O2 kinetics are presented in Table 1 and 351 
Figure 2, whilst average V̇O2 during each exercise stage and subsequent recovery is shown in 352 
Figure 3. Average (~18%, P < 0.001) and end-stage (~11%, P = 0.002) V̇O2 during each 353 
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exercise stage was lower in BR compared to PLA. This was accompanied by an average 354 
reduction in phase II V̇O2 amplitude (~12%, P = 0.025), and a trend for a lower phase II time 355 
constant (~12%, P = 0.07) with BR in response to exercise. There was an effect of the incline 356 
on the MRT (P = 0.04) and a trend for BR (P = 0.08), but no pairwise differences or 357 
interactions (P > 0.05) were found. There were also main effects for recovery V̇O2 (P = 358 
0.001), which on average was lower in BR (~10%). 359 
 360 
 361 
*****Figure 2 here***** 362 
 363 
 364 
 365 
*****Figure 3 here***** 366 
 367 
 368 
The energy cost of exercise was significantly lower across each exercise stage with BR (~8%, 369 
P < 0.001). There was also a significant interaction between exercise gradient and condition 370 
for gross efficiency (P < 0.001), which was lower with BR when walking at 10% (P < 0.001; 371 
d = 1.79), 15% (P = 0.001; d = 1.79) and 20% (P = 0.002; d = 1.05) gradients, but not 372 
different to PLA at any other stage (Figures 4 and 5).  373 
 374 
 375 
*****Figure 4 here**** 376 
 377 
 378 
 379 
 380 
*****Figure 5 here***** 381 
 382 
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 385 
Blood measurements 386 
BR had no effect on blood lactate (P = 0.122), which increased across each exercise stage (P 387 
= 0.002). Plasma insulin did not change significantly from the start to the end of the exercise 388 
protocol (P = 0.104) and was not different between BR and PLA (P = 0.332). Similarly, 389 
blood glucose did not change across gradients (P = 0.799) or between conditions (P = 0.379). 390 
However, there was a significant interaction (P = 0.005) for K+, which was higher after 391 
exercise (4.5 ± 0.3 mmol/L) than before (4.1 ± 0.3 mmol/L) in PLA (P = 0.013; d = 1.33), but 392 
did not change in BR from pre-to-post exercise (4.1 ± 0.3 cf. 4.3 ± 0.2 mmol/L respectively, 393 
P = 0.188).   394 
 395 
*****Table 1 here***** 396 
 397 
Discussion 398 
The main findings of this study further the current understanding of the physiological 399 
responses to exercise mediated by NO3̅ supplementation. In support of our hypothesis, we 400 
have demonstrated that the O2 cost of exercise, the exercise-induced increase in blood [K
+] 401 
and both resting and exercising MAP was reduced, alongside favourable alterations in the 402 
pulmonary V̇O2 kinetics during rest-to-exercise transitions, after consuming NO3̅-rich BR 403 
across a 24-h period. Collectively, these findings support, and extend upon, the reported 404 
physiological effects conferred by BR supplementation, which have many potential 405 
implications for people walking on inclined surfaces as part of their daily tasks. Furthermore, 406 
our findings suggest that the form of locomotion (uphill walking) permits the physiological 407 
changes induced by dietary NO3̅ to manifest during exercise, despite the moderate intensity 408 
of the task. The MAP/V̇O2 at higher external intensities (i.e. 15-20% inclines) also reveals a 409 
phenomenon previously unreported after dietary NO3̅ supplementation.  410 
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 411 
We have demonstrated that acute supplementation of a NO3̅-rich BR supplement lowered 412 
MAP at baseline (rest) and during inclined walking, with seemingly larger effects at gradients 413 
of 1% - 10%, as well as during post-exercise recovery (Figure 1). However, there were no 414 
differences in HR between conditions (Table 1). These findings imply that the net systemic 415 
vasodilatory effect of NO on blood vessels was more active during rest and lower-intensity 416 
exercise (Cw < ~7 J/kg/min) than when exercise intensity was increased (Cw = > ~8 417 
J/kg/min) via inclined walking. Indeed, since MAP was also lower during rest, the net 418 
increase in MAP during 15% and 20% inclines was actually larger in the BR compared to the 419 
PLA condition. We did not anticipate these responses and, consistent with most studies 420 
(Bond et al. 2013; Choi et al. 2016; Kenjale et al. 2011), it was hypothesized that MAP would 421 
be systematically lower throughout the rest and exercise protocol.  422 
 423 
Oggioni et al. (2017) reported very similar findings to that of the current study, albeit among 424 
older adults (64.7 ± 3.0 years), where reductions in diastolic BP were observed at lower 425 
external cycling power output of 20 W – 80 W after BR consumption. During their 426 
subsequent exhaustive trial, both systolic and diastolic BP was equal between PLA and BR 427 
conditions. However, other studies have reported a consistent reduction in BP with increasing 428 
exercise intensity (Bond et al. 2013; Choi et al. 2016; Kenjale et al. 2011). The reasons for 429 
conflicting findings between studies is unclear, but it is noteworthy that each of the studies 430 
with contrasting data to ours used manual sphygmomanometry to measure BP responses, 431 
which rely on human operation and only provide a single caption of end-exercise values, 432 
rather than continuous recordings. Indeed, ambulatory BP recordings have previously been 433 
reduced among hypertensive individuals (Kapil et al. 2015), which avoids the technical 434 
expertise needed to measure manual exercising BP. One explanation for our MAP 435 
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observations could be a greater increase in cardiac output (via stroke volume) in the BR 436 
condition at higher gradients; however, changes in cardiac output have not been observed 437 
after BR supplementation (Oggioni et al. 2017). Redistribution of blood flow towards the 438 
working skeletal musculature has also been demonstrated following BR supplementation 439 
(Horiuchi et al. 2017) and the seemingly necessary exercise-induced net increase in central 440 
BP might also be explained by a similar mechanism. Further investigations are needed to 441 
explore such mechanisms associated with nitrate-induced changes in MAP during different 442 
exercise tasks.  443 
 444 
Consistent with other studies (Bailey et al. 2009; Larsen et al. 2011; Lansely et al. 2011b), we 445 
found a reduction in the O2 cost of exercise, which translated into improvements in GE at 446 
10%, 15% and 20% gradients, among the BR condition compared to PLA (Figure 5). These 447 
findings are most comparable with the reported 12%-14% reductions in O2 cost of exercise 448 
(Lansley et al. 2011b), despite the lower treadmill velocity (3 km/h vs. 4 km/h). The only 449 
other study to use an inclined treadmill protocol (Kenjale et al. 2011) did not increase the 450 
incline beyond 6% and reported minimal effects of BR on ?̇?O2 responses, despite exercising 451 
to exhaustion. We attribute our findings to the type of exercise being performed at higher 452 
gradients. 453 
 454 
When walking uphill at progressively steeper inclines, muscle recruitment strategies are 455 
proportionally altered, such that the leading leg performs longer and more forceful concentric 456 
muscle contractions (i.e. more positive work) (Gotschall and Kram 2006). Based on 457 
Henneman’s size principle, the leading legs would require recruitment from a greater number 458 
of larger motor units (type II fibre). These muscle fibres provide more force but are less 459 
fatigue-resistant and are recruited during a period of increased metabolic demand (Minetti et 460 
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al. 2006). Given the lower-limb forces required to walk on inclined terrain, coupled with the 461 
above-mentioned changes in gait, it is feasible that intermittent occlusion of blood flow will 462 
also result in metabolic perturbation at the working musculature. The increased metabolic 463 
cost, intensity and duration of contractions, coupled with an intermittent occlusion of local 464 
blood flow that occurs during uphill walking, would lead to a mildly hypoxic and acidic 465 
environment, which has been suggested to potentiate the effects of NO at the muscle (Jones et 466 
al. 2016).   467 
 468 
Plasma insulin and glucose concentrations were unaffected by the BR condition compared to 469 
PLA, which has been reported before (Gilchrist et al. 2013), despite the previously described 470 
improvements in glucose homeostasis induced by dietary NO3
- after intense exercise (Wylie 471 
et al. 2013). Our findings are most likely related to the lower intensity of the exercise or the 472 
health status of the participants, who did not present with symptoms of metabolic disease. 473 
There were also no differences in B[La] between conditions after each trial. However, owing 474 
to the organization of the protocol, B[La] was recorded in the 1-min after exercise cessation, 475 
which is unlikely to permit a larger accumulation of lactate in the blood. There was an 476 
interaction between time and condition for [K+], indicating that BR supplementation 477 
attenuated its exercise-induced increase. This confirms the findings of other analyses (Wylie 478 
et al. 2013), which were explained by the accelerated NO3
--NO2
--NO pathway in acidic 479 
environments, potentially blunting the rise in extracellular [K+] in this state. We also 480 
speculate that the increased ATP availability (Larsen et al. 2011) for Na+/K+ pumping or 481 
increases in muscle blood flow (Ferguson et al. 2013) found with NO3
- consumption would 482 
facilitate clearance of K+. We are the first to show this during moderate intensity exercise and 483 
also attribute this finding to the type of exercise performed. Plasma [K+] is increased after 484 
exercise, reflecting a transient disturbance in muscle ion homeostasis and reduced muscle 485 
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excitability. Intermittently walking at 1%-20% inclines for a total of 55-min at an intensity 486 
below the heavy domain was, therefore, sufficient to induce K+ flux into the blood. The 487 
recruitment of muscle fibres when fixed into an inefficient gait cycle is likely to be type II 488 
preferential, thus relying upon musculature that is more fatigable owing to the lower O2 489 
muscle tension (Jones et al. 2016). The observed increase in [K+] in this study can be 490 
considered as a marker of peripheral fatigue that is increased during inclined walking and 491 
attenuated by BR supplementation. Future studies should explore the mechanisms through 492 
which BR exerts this effect.    493 
 494 
?̇?O2 on-kinetics were improved with BR supplementation. Reductions in the amplitude and 495 
non-significant (P = 0.07), yet small effect sizes (d = 0.2 – 0.5), for phase II time constant 496 
from rest to exercise support the findings of others during different exercise types (Bailey et 497 
al. 2009, 2010; Lansley et al. 2011b). To the best of the authors’ knowledge, this is the first 498 
study to demonstrate enhanced recovery of pulmonary O2 after BR supplementation. 499 
Recovery was improved by reducing the resting ?̇?O2 during the intermittent 5-min recovery 500 
periods. These results were accompanied by a lower resting MAP, reflecting reduced 501 
cardiorespiratory stress in response to exercise and, thus, improved exercise tolerance after 502 
BR supplementation.     503 
 504 
There are a variety of occupations in which employees are required to regularly perform 505 
physically demanding tasks. For example, the daily duties of outdoor occupations, such as 506 
military, farming and emergency services, comprise walking activities performed over-507 
ground of varying topography (Ruby et al. 2002). Similarly, physically challenging outdoor 508 
activities, such as mountaineering and hiking, are increasingly popular recreational pursuits, 509 
requiring prolonged sub-maximal hill-walking (Ainslie et al. 2002, 2005; Gottschall and 510 
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Kram 2006). For people engaged in such habitual activities, uphill locomotion is perhaps one 511 
of their most challenging tasks and can lead to an earlier onset of fatigue (Vernillo et al. 512 
2017). Indeed, there is a significant metabolic cost associated with hill-walking, which 513 
increases proportionally with the gradient of the slope and limits the capacity for mechanical 514 
energy transfer (Gottschall and Kram 2006; Minetti et al. 2006). Interventions that increase 515 
hill-walking performance and presumably delay the onset of fatigue via reduced metabolic 516 
costs delay the onset of fatigue, without the need for long-term training adaptation, are 517 
therefore applicable to habitual hill-walkers. Beyond those employed in hazardous 518 
occupations, the capacity to improve the physiological responses to daily exercise, such as 519 
commuting, might also confer a functional and health benefit. Given its apparent capacity to 520 
reduce the appearance of fatigue-related metabolites and lower the O2 cost of exercise, acute 521 
NO3̅ supplementation (BR) could provide a practical intervention for such populations. 522 
 523 
Conclusion 524 
The Cw of walking is reduced and muscle efficiency is increased, particularly at steeper 525 
gradients (10%-20%), after acute BR supplementation. Intermittent recovery of pulmonary 526 
O2 uptake and MAP is ameliorated and selected blood markers of peripheral fatigue are 527 
attenuated by BR supplementation. BP was particularly lowered whilst walking at smaller 528 
gradients (1-10%) after BR supplementation but approaches PLA conditions at higher (15-529 
20%) gradients, despite a lower O2 cost. We collectively attribute these findings to the 530 
inefficient form of locomotion that is required to walk at these gradients, necessitating the 531 
recruitment of more fatigable muscle fibre types during a period of increased metabolic 532 
demand and intermittently hypoxic or mildly acidic environment, know to augment the 533 
reduction of NO2̅ to NO.  However, further research is required to confirm these suggestions. 534 
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These findings have implications for those exercising on terrain of varying topography in 535 
their daily tasks.  536 
 537 
 538 
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Figure legends  737 
 738 
Figure 1. Mean arterial pressure responses to walking at 1%, 5%, 10%, 15% and 20% 739 
inclines and intermittent recovery in beetroot and placebo conditions (n = 8).*Significant (P < 740 
0.05) main effect of BR supplementation 741 
 742 
Figure 2. Pulmonary ?̇?O2 (L/min) responses of a representative subject walking at 1%, 5%, 743 
10%, 20% and 15% inclines and intermittent recovery in beetroot and placebo conditions (n = 744 
8). Data are shown in 5-s averages.  745 
 746 
Figure 3. Mean pulmonary ?̇?O2 (ml/min) responses to walking at 1%, 5%, 10%, 15% and 747 
20% inclines and intermittent recovery in beetroot and placebo conditions (n = 8). 748 
*Significant (P < 0.05) main effect of BR supplementation 749 
 750 
Figure 4. Energy cost (J/kg/min) of walking at 1%, 5%, 10%, 15% and 20% inclines in 751 
beetroot and placebo conditions (n = 8). *Significant (P < 0.05) main effect of BR 752 
supplementation 753 
 754 
Figure 5. Gross efficiency (%) of walking at 1%, 5%, 10%, 15% and 20% inclines in 755 
beetroot and placebo conditions (n = 8). *Significant (P < 0.01) interaction between BR and 756 
PLA. 757 
 758 
 759 
. 760 
 761 
Table title  762 
 763 
Table 1.  Cardiorespiratory responses to walking at 1%, 5%, 10%, 15% and 20% inclines in 764 
beetroot (BR) and placebo (PLA) conditions (n = 8). *Significant (P < 0.05) main effect of 765 
BR supplementation 766 
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End exercise 
VO2 (ml/min)*
On phase II amplitude (ml/min)* 472 ± 125 349 ± 101 742 ± 265 591 ± 237 1078 ± 303 1086 ± 383 1319 ± 291 1158 ± 278 1722 ± 306 1514 ± 368
On phase II time constant (s) 30 ± 16 26 ± 13 35 ± 12 29 ± 7 43 ± 11 38 ± 16 24 ± 10 26 ± 11 37 ± 18 30 ± 11
Mean response time (s) 41 ± 18 39 ± 14 47 ± 12 42 ± 9 56 ± 12 52 ± 16 32 ± 11 37 ± 13 48 ± 18 42 ± 9
Exercising Heart rate (b/min) 80 ± 11 79 ± 12 88 ± 12 86 ± 13 98 ± 13 97 ± 12 113 ± 19 109 ± 20 120 ± 17 116 ± 17
Resting heart rate (b/min) 71 ± 10 68 ± 12 78 ± 12 76 ± 10 81 ± 13 77 ± 11 87 ± 20 79 ± 14 89 ± 18 84 ± 18
±
PLA BR PLA BR
1% 5% 10% 15% 20%
PLA BR PLA BR PLA BR
794 ± 204 643 285137 1076 ± 277 931 ± 221 1363 ± 20831249 ± 264 1707 ± 287 1550 ± 310 ± 389 1877 ± 352
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